ON TOPIC QUESTION - We do know Leo is in the process of dealing with potential partners. What I don't know is what the production costs will be when fully approved, especially important about that is in comparison to other competitive drugs production costs. That alone could have an effect on end usage. Now assuming that the IPIX drugs can be produced cheaper without making they less affective. Could/should in time Leo or someone in the company also make a deal with the medical insurance companies to sell the drugs at a lower price (profitability maintained of course) to NOT HAVE any co-pay crap on use of our drugs to in need patients. Seems to me that would accelerate sales. Sell for a little less but take a LARGER SHARE of the market.

JUST A THOUGHT